These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 21229256)
1. Similarities and differences between primary and secondary degeneration of the optic nerve and the effect of minocycline. Levkovitch-Verbin H; Spierer O; Vander S; Dardik R Graefes Arch Clin Exp Ophthalmol; 2011 Jun; 249(6):849-57. PubMed ID: 21229256 [TBL] [Abstract][Full Text] [Related]
2. Minocycline mechanism of neuroprotection involves the Bcl-2 gene family in optic nerve transection. Levkovitch-Verbin H; Waserzoog Y; Vander S; Makarovsky D; Ilia P Int J Neurosci; 2014 Oct; 124(10):755-61. PubMed ID: 24410139 [TBL] [Abstract][Full Text] [Related]
4. Mechanism of retinal ganglion cells death in secondary degeneration of the optic nerve. Levkovitch-Verbin H; Dardik R; Vander S; Melamed S Exp Eye Res; 2010 Aug; 91(2):127-34. PubMed ID: 19951705 [TBL] [Abstract][Full Text] [Related]
5. Alpha2-adrenoreceptor agonists are neuroprotective in a rat model of optic nerve degeneration. Yoles E; Wheeler LA; Schwartz M Invest Ophthalmol Vis Sci; 1999 Jan; 40(1):65-73. PubMed ID: 9888428 [TBL] [Abstract][Full Text] [Related]
6. Reduced retina microglial activation and improved optic nerve integrity with minocycline treatment in the DBA/2J mouse model of glaucoma. Bosco A; Inman DM; Steele MR; Wu G; Soto I; Marsh-Armstrong N; Hubbard WC; Calkins DJ; Horner PJ; Vetter ML Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1437-46. PubMed ID: 18385061 [TBL] [Abstract][Full Text] [Related]
7. Minocycline delays death of retinal ganglion cells in experimental glaucoma and after optic nerve transection. Levkovitch-Verbin H; Kalev-Landoy M; Habot-Wilner Z; Melamed S Arch Ophthalmol; 2006 Apr; 124(4):520-6. PubMed ID: 16606878 [TBL] [Abstract][Full Text] [Related]
8. The effect of ginkgo biloba on the rat retinal ganglion cell survival in the optic nerve crush model. Ma K; Xu L; Zhang H; Zhang S; Pu M; Jonas JB Acta Ophthalmol; 2010 Aug; 88(5):553-7. PubMed ID: 19681765 [TBL] [Abstract][Full Text] [Related]
9. Regulation of cell death and survival pathways in secondary degeneration of the optic nerve - a long-term study. Vander S; Levkovitch-Verbin H Curr Eye Res; 2012 Aug; 37(8):740-8. PubMed ID: 22631427 [TBL] [Abstract][Full Text] [Related]
10. A model to study differences between primary and secondary degeneration of retinal ganglion cells in rats by partial optic nerve transection. Levkovitch-Verbin H; Quigley HA; Martin KR; Zack DJ; Pease ME; Valenta DF Invest Ophthalmol Vis Sci; 2003 Aug; 44(8):3388-93. PubMed ID: 12882786 [TBL] [Abstract][Full Text] [Related]
11. Lack of protective effect of local administration of triamcinolone or systemic treatment with methylprednisolone against damages caused by optic nerve crush in rats. Huang TL; Chang CH; Lin KH; Sheu MM; Tsai RK Exp Eye Res; 2011 Feb; 92(2):112-9. PubMed ID: 21185832 [TBL] [Abstract][Full Text] [Related]
12. Neuroprotective effects of recombinant human granulocyte colony-stimulating factor (G-CSF) in neurodegeneration after optic nerve crush in rats. Tsai RK; Chang CH; Wang HZ Exp Eye Res; 2008 Sep; 87(3):242-50. PubMed ID: 18602391 [TBL] [Abstract][Full Text] [Related]
13. Neuroprotective effect of 4-(Phenylsulfanyl)butan-2-one on optic nerve crush model in rats. Chien JY; Sheu JH; Wen ZH; Tsai RK; Huang SP Exp Eye Res; 2016 Feb; 143():148-57. PubMed ID: 26472213 [TBL] [Abstract][Full Text] [Related]
14. Neuroprotective effects of tempol acyl esters against retinal ganglion cell death in a rat partial optic nerve crush model. Thaler S; Fiedorowicz M; Grieb P; Wypych Z; Knap N; Borowik T; Zawada K; Kaminski J; Wozniak M; Rejdak R; Zrenner E; Schuettauf F Acta Ophthalmol; 2011 Nov; 89(7):e555-60. PubMed ID: 21645284 [TBL] [Abstract][Full Text] [Related]
15. The neuropeptide NAP provides neuroprotection against retinal ganglion cell damage after retinal ischemia and optic nerve crush. Jehle T; Dimitriu C; Auer S; Knoth R; Vidal-Sanz M; Gozes I; Lagrèze WA Graefes Arch Clin Exp Ophthalmol; 2008 Sep; 246(9):1255-63. PubMed ID: 18414890 [TBL] [Abstract][Full Text] [Related]
16. Neuroprotective effect of nipradilol [3,4-dihydro-8-(2-hydroxy-3-isopropylamino)-propoxy-3-nitroxy-2H-1-benzopyran] in a rat model of optic nerve degeneration. Karim MZ; Sawada A; Mizuno K; Kawakami H; Ishida K; Yamamoto T J Glaucoma; 2009 Jan; 18(1):26-31. PubMed ID: 19142131 [TBL] [Abstract][Full Text] [Related]
17. A novel neuroprotectant against retinal ganglion cell damage in a glaucoma model and an optic nerve crush model in the rat. Maeda K; Sawada A; Matsubara M; Nakai Y; Hara A; Yamamoto T Invest Ophthalmol Vis Sci; 2004 Mar; 45(3):851-6. PubMed ID: 14985301 [TBL] [Abstract][Full Text] [Related]
18. Anti-apoptotic effects of human granulocyte colony-stimulating factor (G-CSF) on retinal ganglion cells after optic nerve crush are PI3K/AKT-dependent. Tsai RK; Chang CH; Sheu MM; Huang ZL Exp Eye Res; 2010 May; 90(5):537-45. PubMed ID: 20144610 [TBL] [Abstract][Full Text] [Related]
19. Effects of minocycline and tetracycline on retinal ganglion cell survival after axotomy. Baptiste DC; Powell KJ; Jollimore CA; Hamilton C; LeVatte TL; Archibald ML; Chauhan BC; Robertson GS; Kelly ME Neuroscience; 2005; 134(2):575-82. PubMed ID: 15939545 [TBL] [Abstract][Full Text] [Related]
20. Effect of glatiramer acetate on primary and secondary degeneration of retinal ganglion cells in the rat. Blair M; Pease ME; Hammond J; Valenta D; Kielczewski J; Levkovitch-Verbin H; Quigley H Invest Ophthalmol Vis Sci; 2005 Mar; 46(3):884-90. PubMed ID: 15728544 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]